---
figid: PMC3655553__nihms264626f1
figtitle: 'Beta-Adrenergic Receptor Signaling in Heart Failure and Longevity: Targeting
  Adenylyl Cyclase Type 5'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3655553
filename: nihms264626f1.jpg
figlink: /pmc/articles/PMC3655553/figure/F1/
number: F1
caption: Upon β-AR stimulation, the Gsα subunit-bound AC produces cAMP which activates
  target molecules, PKA and Epac. PKA regulates Ca2+ homeostasis through SR and LTCC,
  increases contractility. Under conditions of excessive sympathetic stimulation,
  PKA-induced Ca2+ leads to hypertrophy. On the other hand, activated PKA inhibits
  Raf, which results in the activation of the MEK/ERK signaling, and thus suppression
  of apoptosis. In contrast, Epac, the other target protein of cAMP than PKA, induces
  myocyte apoptosis via the P38MAPK pathway. Upon activation of β2-AR, the Giβγ subunits
  are released and activate the PI3K/Akt pathway. Activated Akt inhibits apoptosis,
  and accelerates hypertrophy
papertitle: 'Modulation of β-Adrenergic Receptor Signaling in Heart Failure and Longevity:
  Targeting Adenylyl Cyclase Type 5.'
reftext: David Ho, et al. Heart Fail Rev. ;15(5):495-512.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9783981
figid_alias: PMC3655553__F1
figtype: Figure
redirect_from: /figures/PMC3655553__F1
ndex: 4a0b5b0e-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3655553__nihms264626f1.html
  '@type': Dataset
  description: Upon β-AR stimulation, the Gsα subunit-bound AC produces cAMP which
    activates target molecules, PKA and Epac. PKA regulates Ca2+ homeostasis through
    SR and LTCC, increases contractility. Under conditions of excessive sympathetic
    stimulation, PKA-induced Ca2+ leads to hypertrophy. On the other hand, activated
    PKA inhibits Raf, which results in the activation of the MEK/ERK signaling, and
    thus suppression of apoptosis. In contrast, Epac, the other target protein of
    cAMP than PKA, induces myocyte apoptosis via the P38MAPK pathway. Upon activation
    of β2-AR, the Giβγ subunits are released and activate the PI3K/Akt pathway. Activated
    Akt inhibits apoptosis, and accelerates hypertrophy
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ac
  - gs
  - ATPsynbeta
  - Atpalpha
  - Galphai
  - mthl5
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Epac
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - MKP-4
  - p38b
  - rl
  - lic
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - sr
  - Akt
  - CaMKII
  - Dsor1
  - Mtk
  - Raf
  - Erk7
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - GNAS
  - GNAL
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - ATP8A2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - RAPGEF3
  - RAPGEF4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - GRAP2
  - AHSA1
  - POLDIP2
  - CCNG1
  - CCNG2
  - AKT1
  - AKT2
  - AKT3
  - CAMK2G
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - Cancer
---
